NO165292C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive azabicyclo(3.3.1)nonaner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive azabicyclo(3.3.1)nonaner.

Info

Publication number
NO165292C
NO165292C NO844750A NO844750A NO165292C NO 165292 C NO165292 C NO 165292C NO 844750 A NO844750 A NO 844750A NO 844750 A NO844750 A NO 844750A NO 165292 C NO165292 C NO 165292C
Authority
NO
Norway
Prior art keywords
nonanes
preparation
therapeutic active
analogy procedure
azabicyclo
Prior art date
Application number
NO844750A
Other languages
English (en)
Norwegian (no)
Other versions
NO165292B (no
NO844750L (no
Inventor
Karoly Mador
Gabor Kraiss
Margit Pellinoisz
Egon Karpati
Laszlo Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO844750L publication Critical patent/NO844750L/no
Publication of NO165292B publication Critical patent/NO165292B/no
Publication of NO165292C publication Critical patent/NO165292C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO844750A 1983-11-30 1984-11-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azabicyclo(3.3.1)nonaner. NO165292C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834096A HU190511B (en) 1983-11-30 1983-11-30 Process for preparing new azabicyclic compounds

Publications (3)

Publication Number Publication Date
NO844750L NO844750L (no) 1985-05-31
NO165292B NO165292B (no) 1990-10-15
NO165292C true NO165292C (no) 1991-01-23

Family

ID=10966876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844750A NO165292C (no) 1983-11-30 1984-11-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive azabicyclo(3.3.1)nonaner.

Country Status (31)

Country Link
US (1) US4769373A (da)
JP (1) JPS60185766A (da)
AR (1) AR241492A1 (da)
AT (1) AT388730B (da)
AU (1) AU570285B2 (da)
BE (1) BE901174A (da)
CA (1) CA1280751C (da)
CH (1) CH663615A5 (da)
CS (1) CS273602B2 (da)
DD (1) DD231073A1 (da)
DE (1) DE3442365A1 (da)
DK (1) DK568584A (da)
EG (1) EG16845A (da)
ES (2) ES8604579A1 (da)
FI (1) FI80445C (da)
FR (1) FR2555580B1 (da)
GB (1) GB2150558B (da)
GR (1) GR81084B (da)
HU (1) HU190511B (da)
IL (1) IL73421A (da)
IT (1) IT1178638B (da)
MX (1) MX157611A (da)
NL (1) NL8403634A (da)
NO (1) NO165292C (da)
PH (1) PH19659A (da)
PL (2) PL144546B1 (da)
PT (1) PT79568B (da)
SE (1) SE460418B (da)
SU (1) SU1395141A3 (da)
YU (1) YU45681B (da)
ZA (1) ZA848721B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525672D0 (en) * 2005-12-16 2006-01-25 Novartis Ag Organic compounds
CN111187210B (zh) * 2020-01-08 2022-05-03 成都中医药大学 一种热解型二萜生物碱化合物及其制备方法和用途
CN113149905B (zh) * 2021-02-24 2022-04-29 成都中医药大学 一种抗心律失常的化合物及其制药用途
CN113149906B (zh) * 2021-02-24 2022-05-17 成都中医药大学 一种抗心律失常药物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195746A (en) * 1967-06-07 1970-06-24 Yoshitomi Pharmaceutical 3-Azabicyclo [3,3,1] Nonane Derivatives
US3741973A (en) * 1967-09-11 1973-06-26 Upjohn Co Oxygenated 3-azabicyclo(3.3.1)nonanes
GB1393253A (en) * 1971-09-10 1975-05-07 Wyeth John & Brother Ltd 3-azabicyclo-3,3,1-nonanes

Also Published As

Publication number Publication date
PL254457A1 (en) 1987-03-23
AU3602984A (en) 1985-06-06
GB2150558B (en) 1987-10-14
PH19659A (en) 1986-06-09
PT79568B (en) 1986-09-11
FI80445C (fi) 1990-06-11
YU200684A (en) 1987-10-31
GB2150558A (en) 1985-07-03
IT8423805A0 (it) 1984-11-29
EG16845A (en) 1990-12-30
ES538069A0 (es) 1986-02-01
PL250635A1 (en) 1985-11-05
CA1280751C (en) 1991-02-26
NL8403634A (nl) 1985-06-17
ES8606338A1 (es) 1986-04-01
SU1395141A3 (ru) 1988-05-07
IL73421A (en) 1987-12-31
PL142604B1 (en) 1987-11-30
DK568584D0 (da) 1984-11-29
NO165292B (no) 1990-10-15
US4769373A (en) 1988-09-06
SE460418B (sv) 1989-10-09
AU570285B2 (en) 1988-03-10
FI844480A0 (fi) 1984-11-15
SE8406046L (sv) 1985-05-31
ES548112A0 (es) 1986-04-01
BE901174A (fr) 1985-05-30
FI80445B (fi) 1990-02-28
NO844750L (no) 1985-05-31
PT79568A (en) 1984-12-01
PL144546B1 (en) 1988-06-30
CS920184A2 (en) 1990-08-14
HUT35647A (en) 1985-07-29
ES8604579A1 (es) 1986-02-01
DK568584A (da) 1985-05-31
ATA352184A (de) 1989-01-15
JPS60185766A (ja) 1985-09-21
YU45681B (sh) 1992-07-20
DE3442365A1 (de) 1985-06-05
IT1178638B (it) 1987-09-09
GB8428143D0 (en) 1984-12-12
DD231073A1 (de) 1985-12-18
CH663615A5 (de) 1987-12-31
CS273602B2 (en) 1991-03-12
HU190511B (en) 1986-09-29
FR2555580A1 (fr) 1985-05-31
AR241492A1 (es) 1992-07-31
SE8406046D0 (sv) 1984-11-29
ZA848721B (en) 1985-06-26
GR81084B (en) 1985-03-29
MX157611A (es) 1988-12-05
FI844480L (fi) 1985-05-31
FR2555580B1 (fr) 1988-10-28
AT388730B (de) 1989-08-25

Similar Documents

Publication Publication Date Title
NO171787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO171272C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO165292C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azabicyclo(3.3.1)nonaner.
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO160001C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.